Document:

exv10w1

 

Exhibit 10.1

INCREMENTAL COMMITMENT AGREEMENT

November 13, 2007

RCN Corporation

196 Van Buren St.

Suite 300

Herndon, VA 20170

Attention: Chief Financial Officer

          re Incremental Term Loan Commitments

Ladies and Gentlemen:

          Reference is hereby made to the Credit Agreement, dated as of May 25, 2007 (as amended,
modified, restated or supplemented from time to time, the “Credit Agreement”), among RCN
Corporation (the “Borrower or “you”), the lenders from time to time party thereto
(the “Lenders”) and Deutsche Bank Trust Company Americas, as Administrative Agent (in such
capacity, together with any successor administrative agent, the “Administrative Agent”).
Unless otherwise defined herein, capitalized terms used herein shall have the meanings set forth in
the Credit Agreement.

          Each Lender (each an “Incremental Lender”) party to this letter agreement (this
“Agreement”) hereby severally agrees to provide the Incremental Commitment set forth
opposite its name on Annex I attached hereto (for each such Incremental Lender, its
“Incremental Commitment”). Each Incremental Commitment provided pursuant to this Agreement
shall be subject to the terms and conditions set forth in the Credit Agreement, including Section
1.14 thereof.

          Each Incremental Lender acknowledges and agrees that the Incremental Commitments provided
pursuant to this Agreement, in the aggregate amount for each tranche of Incremental Commitments as
set forth on Annex I hereto, shall constitute Incremental Term Loan Commitments under, and as
defined in, the Credit Agreement. Each Incremental Lender agreeing to provide an Incremental
Commitment pursuant to this Agreement, the Borrower and the Administrative Agent acknowledge and
agree that, upon the incurrence of Incremental Term Loans pursuant to the Incremental Commitments
provided pursuant to this Agreement, such Incremental Term Loans shall constitute Term Loans for
all purposes of the Credit Agreement and the other Credit Documents.

 

 

          Each Incremental Lender and the Borrower further agree that, with respect to the Incremental
Commitments provided by such Incremental Lender pursuant to this Agreement, such Incremental Lender
shall receive such upfront fees as have been separately agreed, which upfront fee shall be due and
payable as has been separately agreed.

          Each Incremental Lender party to this Agreement (i) confirms that it has received a copy of
the Credit Agreement and the other Credit Documents, together with copies of the financial
statements referred to therein and such other documents and information as it has deemed
appropriate to make its own credit analysis and decision to enter into this Agreement and, to the
extent applicable, to become a Lender under the Credit Agreement, (ii) agrees that it will,
independently and without reliance upon the Administrative Agent or any other Lender and based on
such documents and information as it shall deem appropriate at the time, continue to make its own
credit decisions in taking or not taking action under the Credit Agreement, (iii) appoints and
authorizes the Administrative Agent and the Collateral Agent to take such action as agent on its
behalf and to exercise such powers under the Credit Agreement and the other Credit Documents as are
delegated to the Administrative Agent and the Collateral Agent, as the case may be, by the terms
thereof, together with such powers as are reasonably incidental thereto, (iv) agrees that it will
perform in accordance with their terms all of the obligations which by the terms of the Credit
Agreement are required to be performed by it as a Lender, and (v) in the case of each lending
institution (not already a Lender) organized under the laws of a jurisdiction outside the United
States, attaches the applicable forms described in Section 4.04(b) of the Credit Agreement
certifying as to its entitlement to a complete exemption from United States withholding taxes with
respect to all payments to be made under the Credit Agreement and the other Credit Documents.

          Upon the date of (i) the execution of a counterpart of this Agreement by such Incremental
Lenders, the Administrative Agent and the Borrower and the delivery thereof to the Administrative
Agent (including by facsimile), (ii) the payment of any fees required in connection herewith and
(iii) the satisfaction of any conditions precedent set forth in Section 6 of Annex I hereto (such
date, the “Agreement Effective Date”) each Incremental Lender party hereto agreeing to
provide an Incremental Commitment pursuant to this Agreement (x) shall become a party to the Credit
Agreement, (y) shall be obligated to make the Incremental Term Loans provided to be made by it as
provided in this Agreement on the terms, and subject to the conditions, set forth herein and in the
Credit Agreement and (z) to the extent provided in this Agreement, shall have the rights and
obligations of a Lender thereunder and under the other Credit Documents. The maximum number of
drawings with respect to the Incremental Term Loan Commitments provided pursuant to this Agreement
shall be as specified in Annex I attached hereto. Furthermore, any undrawn Incremental Term Loan
Commitments provided pursuant to this Agreement shall expire on the date specified in Annex I
attached hereto.

          The Borrower agrees that the terms contained in Annex I attached hereto (including without
limitation, those contained in Sections 8, 9, 10, 11 and 12 thereof) constitute terms applicable to
the Incremental Commitments provided hereunder and the Incremental Term Loans made pursuant hereto.

          The Borrower acknowledges and agrees that (i) it shall be liable for all Obligations with
respect to the Incremental Commitments provided hereby including, without

 

 

limitation, any Loans made pursuant thereto and (ii) all such Obligations (including any such
Loans) shall be entitled to the benefits of the Security Documents.

          Each Subsidiary Guarantor acknowledges and agrees that all Obligations with respect to the
Incremental Commitments provided hereby and any Loans made pursuant thereto shall (i) be fully
guaranteed pursuant to the Subsidiaries Guaranty in accordance with the terms and provisions
thereof and (ii) be entitled to the benefits of the Security Documents.

          Attached hereto as Annex II is an opinion of Andrews Kurth LLP, counsel to the Borrower,
delivered as required pursuant to Section 1.14(b)(iv) of the Credit Agreement.

          You may accept this Agreement by executing the enclosed copies in the space provided below,
and returning a copy of same to us before the close of business on November 13, 2007. If you do
not so accept this Agreement by such time, our Incremental Commitments set forth in this Agreement
shall be deemed cancelled.

          After the execution and delivery to the Administrative Agent of a fully executed copy of this
Agreement (including by way of counterparts and by facsimile) by the parties hereto, this Agreement
shall constitute a Credit Document and may only be changed, modified or varied by written
instrument in accordance with the requirements for the modification of Credit Documents pursuant to
Section 13.12 of the Credit Agreement.

* * *

 

 

          THIS AGREEMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAW OF THE STATE OF
NEW YORK.

  Very truly yours,

	 	 	 	 	 	 	 
	 	 	DEUTSCHE BANK TRUST COMPANY AMERICAS
	 
	 	 	 	 	 	 
	 

	 	By
	 	s/ Anca Trifan
	 	 
	 

	 	 	 	 	 
	 

	 	 
	 	

Name: Anca Trifan

Title: Director
	 	 
	 
	 	 	 	 	 	 
	 

	 	By
	 	s/ Yvonne Tilden	 	 
	 

	 	 	 	 	 
	 

	 	 	 	Name: Yvonne Tilden

Title: Vice President	 	 

 

 

Agreed and Accepted

this 13th day of November, 2007:

	 	 	 	 	 
	RCN CORPORATION	 	 
	 
	 	 	 	 
	By:

	 	s/ Michael T. Sicoli
 

Name: Michael T. Sicoli 

Title: Executive Vice President and Chief Financial Officer
	 

 

 

	 	 	 	 	 
	DEUTSCHE BANK TRUST COMPANY AMERICAS,

     as Administrative Agent	 	 
	 
	 	 	 	 
	By:

	 	s/ Anca Trifan
 

Name: Anca Trifan 

Title: Director
	 	 
	 
	 	 	 	 
	By:

	 	s/ Yvonne Tilden	 	 
	 

	 	 	 	 
	 

	 	Name: Yvonne Tilden

Title: Vice President	 	 

 

 

Each Subsidiary Guarantor acknowledges and agrees to the foregoing provisions of this Incremental
Commitment Agreement, specifically including the acknowledgments and agreements made by it
pursuant to the eighth paragraph of the Incremental Commitment Agreement.

	 	 	 	 	 	 	 
	 	 	21ST CENTURY TELECOM SERVICES, INC.

BRAINSTORM NETWORKS, INC.

HOT SPOTS PRODUCTIONS, INC.

ON TV, INC.

RCN-BECOCOM, INC.

RCN CABLE TV OF CHICAGO, INC.

RCN DIGITAL SERVICES, LLC	 	 
	 

	 	 	 	By: RCN Corporation, its managing member	 	 
	 	 	RCN ENTERTAINMENT, INC.

RCN FINANCE, LLC	 	 
	 

	 	 	 	By: RCN Corporation, its managing member	 	 
	 	 	RCN FINANCIAL MANAGEMENT, INC.

RCN INTERNATIONAL HOLDINGS, INC.

RCN INTERNET SERVICES, INC.

RCN NEW YORK COMMUNICATIONS, LLC	 	 
	 

	 	 	 	By: RCN Telecom Services, Inc., its managing member	 	 
	 	 	RCN TELECOM SERVICES, INC.

RCN TELECOM SERVICES OF ILLINOIS, LLC	 	 
	 

	 	 	 	By: RCN Corporation, its managing member	 	 
	 	 	RCN TELECOM SERVICES OF MASSACHUSETTS, INC. 

RCN TELECOM SERVICES OF PHILADELPHIA, INC. 

RCN TELECOM SERVICES OF VIRGINIA, INC. 

RCN TELECOM SERVICES OF WASHINGTON D.C., INC. 

RFM 2, LLC	 	 
	 

	 	 	 	By: RCN Corporation, its managing member	 	 
	 	 	RLH PROPERTY CORPORATION

STARPOWER COMMUNICATIONS, LLC	 	 
	 

	 	 	 	By: RCN Telecom Services of Washington D.C., Inc., its
managing member	 	 
	 	 	TEC AIR, INC.

UNET HOLDING, INC., as Guarantors	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	s/ Michael T. Sicoli
 

Name: Michael T. Sicoli
	 	 
	 

	 	 	 	Title: Executive Vice President and CFO	 	 
	 
	 	 	 	 	 	 
	 	 	RAVEN ACQUISITION CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	s/ Michael T. Sicoli
 

Name: Michael T. Sicoli
	 	 
	 

	 	 	 	Title: Executive Vice President and CFO	 	 

 

 

ANNEX I

TO INCREMENTAL

COMMITMENT

AGREEMENT

DATED NOVEMBER 13, 2007

TERMS AND CONDITIONS FOR 

INCREMENTAL COMMITMENT AGREEMENT

	1.	 	Name of Tranche to which Incremental Commitments will be added, or which will be newly
created: Initial Term Loans. The Incremental Term Loans made pursuant hereto shall be
available in a single draw, to occur upon satisfaction of the conditions hereinafter described
in section 6 and on or prior to November 20, 2007.
	 
	2.	 	Incremental Commitment Amounts (as of the Agreement Effective Date):

	 	 	 	 	 
	Name of Lender	 	Amount of Incremental Term Loan Commitment
	Deutsche Bank Trust Company Americas
	 	$	200,000,000	 
	 
	Total
	 	$	200,000,000	 

	3.	 	Maturity Date: May 25, 2014.
	 
	4.	 	Dates for, and amounts of, Scheduled Repayments: As provided in the last sentence of Section
4.02(b) of the Credit Agreement, each remaining Initial Term Loan Scheduled Repayment shall be
proportionally increased (with the aggregate increases to the then remaining Initial Term Loan
Scheduled Repayments to equal the aggregate principal amount of the new Incremental Term Loans
being incurred hereunder). The remaining Initial Term Loan Scheduled Repayment Dates on the
date hereof and the respective amounts of the increases thereto, is set forth in the table
below:

	 	 	 	 	 
	Initial Term Loan Scheduled	 	 
	Repayment Date:	 	Amount of Increase
	December 31, 2007
	 	$	501,253.13	 
	March 31, 2008
	 	$	501,253.13	 
	June 30, 2008
	 	$	501,253.13	 
	 
	 	 	 	 
	September 30, 2008
	 	$	501,253.13	 
	December 31, 2008
	 	$	501,253.13	 
	March 31, 2009
	 	$	501,253.13	 
	June 30, 2009
	 	$	501,253.13	 
	 
	 	 	 	 
	September 30, 2009
	 	$	501,253.13	 
	December 31, 2009
	 	$	501,253.13	 
	March 31, 2010
	 	$	501,253.13	 
	June 30, 2010
	 	$	501,253.13	 
	 
	 	 	 	 
	September 30, 2010
	 	$	501,253.13	 
	December 31, 2010
	 	$	501,253.13	 
	March 31, 2011
	 	$	501,253.13	 

 

 

Annex I

Page 2

	 	 	 	 	 
	Initial Term Loan Scheduled	 	 
	Repayment Date:	 	Amount of Increase
	June 30, 2011
	 	$	501,253.13	 
	 
	 	 	 	 
	September 30, 2011
	 	$	501,253.13	 
	December 31, 2011
	 	$	501,253.13	 
	March 31, 2012
	 	$	501,253.13	 
	June 30, 2012
	 	$	501,253.13	 
	 
	 	 	 	 
	September 30, 2012
	 	$	501,253.13	 
	December 31, 2012
	 	$	501,253.13	 
	March 31, 2013
	 	$	501,253.13	 
	June 30, 2013
	 	$	501,253.13	 
	 
	 	 	 	 
	September 30, 2013
	 	$	501,253.13	 
	December 31, 2013
	 	$	501,253.13	 
	March 31, 2014
	 	$	501,253.13	 
	 
	 	 	 	 
	Initial Term Loan Maturity Date
	 	$	186,967,418.62	 

	5.	 	In addition to the conditions set forth above, the effectiveness of this Agreement and the
Incremental Commitments provided hereunder are subject to satisfaction of the following
conditions:

	 	(i)	 	The Agreement and Plan of Merger, dated as of June 24, 2007, among the Borrower,
Raven Acquisition Corporation and Neon Communications Group, Inc. (such agreement,
together with all of the schedules thereto, the “Acquisition Agreement”) shall
have been entered into in the form furnished to the Administrative Agent on or prior to
June 24, 2007, and the Acquisition Agreement shall not have been modified in any
material manner without the prior written consent of the Administrative Agent. All
conditions precedent to the consummation of the Transaction (as defined below) set forth
in the Acquisition Agreement (as defined below) shall have been satisfied in all
material respects, and no material closing condition shall have been waived, except with
the consent of the Administrative Agent. Each component of the Transaction shall be
consummated substantially concurrently with the incurrence of Incremental Term Loans
hereunder in accordance with the documentation therefor and all applicable laws. As
used herein, the “Transaction” shall mean (i) the incurrence of Initial Term Loans
pursuant to this Agreement and (ii) acquisition by the Borrower of Neon Communications
Group, Inc. pursuant to the Acquisition Agreement (“the Acquisition”).
	 
	 	(ii)	 	Except as contemplated by the Acquisition Agreement, since September 30, 2006,
there shall not have been any event or occurrence of any condition that has had or would
reasonably be expected to have, individually or in the aggregate, a “Material Adverse
Effect” (as defined in the Acquisition Agreement as in effect on June 24, 2007).
	 
	 	(iii)	 	The funds provided pursuant to the Incremental Commitments together with cash on
hand and/or proceeds of Revolving Loans, shall be sufficient to pay all amounts owing in
connection with the Transaction.

 

 

Annex I

Page 3

	 	(iv)	 	All of the requirements of the Credit Agreement applicable to the provision and
incurrence of the Incremental Term Loans, including, without limitation, Sections 1.01,
1.14 and 6 thereof, shall have been satisfied to the reasonable satisfaction of
Administrative Agent.
	 
	 	(v)	 	All necessary governmental (domestic and foreign) approvals and/or consents in
connection with the Incremental Commitments shall have been obtained and remain in
effect, and all applicable waiting periods shall have expired without any action being
taken by any competent authority which restrains, prevents, or imposes materially
adverse conditions upon, the consummation of the Incremental Commitments. Additionally,
there shall not exist any judgment, order, injunction or other restraint prohibiting or
imposing materially adverse conditions upon the Incremental Commitments.
	 
	 	(vi)	 	The incurrence of the Incremental Term Loans (and all guaranties thereof and
security therefor), as well as the Transaction and the consummation thereof, shall be in
compliance with all applicable requirements of Regulations T, U and X of the Federal
Reserve Board.
	 
	 	(vii)	 	The Administrative Agent shall have received opinions of counsel from (i)
Andrews Kurth LLP, counsel to the Credit Parties and (ii) Benjamin Preston, which
opinions shall be addressed to the Lenders, dated the Agreement Effective Date, and be
in form and substance, reasonably satisfactory to the Administrative Agent.
	 
	 	(viii)	 	All reasonable costs, fees, expenses (including, without limitation, reasonable legal
fees and expenses) and other compensation contemplated hereby, payable to the
Administrative Agent and the Incremental Lenders or otherwise payable in respect of the
Transaction shall have been paid to the extent due.
	 
	 	(ix)	 	The Borrower will, and will cause each of the other Credit Parties to, make
arrangements reasonably satisfactory to the Administrative Agent to grant to the
Collateral Agent for the benefit of the Secured Creditors security interests and
Mortgages in such of the Borrower’s and such other Credit Parties’ assets, properties
and owned real properties as are not covered by the original Security Documents and
which have been acquired by the Borrower or its Subsidiaries pursuant to the Acquisition
Agreement immediately following the Acquisition on the Agreement Effective Date,
including taking the following actions:

	 	a.	 	each Subsidiary of the Borrower acquired pursuant to the Acquisition
Agreement (such Subsidiary, a “Newly Acquired Subsidiary”) shall duly
authorize, execute and deliver the Joinder Agreement in the form of Exhibit
A hereto and shall deliver to the Collateral Agent the following:

	 	I.	 	endorsed in blank in the case of promissory notes
constituting Pledge Agreement Collateral, together with executed and undated
endorsements for transfer in the case of certificated Equity Interests
constituting certificated Pledge Agreement Collateral;

 

 

Annex I

Page 4

	 	II.	 	proper financing statements (Form UCC-1 or the
equivalent) authorized for filing under the UCC or other appropriate filing
offices of each jurisdiction as may be necessary or, in the reasonable
opinion of the Collateral Agent, desirable, to perfect the security
interests purported to be created by the Security Agreement;
	 
	 	III.	 	certified copies of requests for information or copies
(Form UCC-11), or equivalent reports as of a recent date, listing all
effective financing statements that name the Newly Acquired Subsidiaries as
debtor and that are filed in the jurisdictions referred to in clause (i)
above and in such other jurisdictions as the Collateral Agent may deem
necessary or desirable (in its sole discretion) to ensure the perfection of
the security interests purported to be created by the Security Agreement,
together with copies of such other financing statements that name the Newly
Acquired Subsidiaries as debtor (none of which shall cover any of the
Collateral except (x) to the extent evidencing Permitted Liens or (y) those
in respect of which the Collateral Agent shall have received termination
statements (Form UCC-3) or such other termination statements as shall be required by
local law authorized for filing);
	 
	 	IV.	 	evidence of the completion of all other recordings and
filings of, or with respect to, the Security Agreement as may be necessary
or, in the reasonable opinion of the Collateral Agent, desirable, to perfect
the security interests intended to be created by the Security Agreement;
	 
	 	V.	 	evidence that all other actions necessary or, in the
reasonable opinion of the Collateral Agent, desirable to perfect and protect
the security interests purported to be created by the Pledge Agreement and
the Security Agreement have been taken; and

	 	b.	 	each Newly Acquired Subsidiary shall deliver to the Administrative
Agent a certificate, dated the Agreement Effective Date, signed by a secretary or
assistant secretary of each Newly Acquired Subsidiary and attested to by an
authorized officer of such Newly Acquired Subsidiary, substantially in the form of
Exhibit G-1 to the Credit Agreement with appropriate insertions, together with
copies of the certificate of incorporation, by-laws or equivalent organizational
documents of such Credit Party and the resolutions of such Newly Acquired
Subsidiary authorizing the transactions referred to herein and occurring on or
prior to the Agreement Effective Date.

	 	(x)	 	On the Agreement Effective Date, the Administrative Agent shall have received
from the Borrower a certificate, substantially in the form of Exhibit B, with
appropriate insertions, dated such date and signed on behalf of the Borrower by an
Authorized Representative of the Borrower.

 

 

Annex I

Page 5

	6.	 	On the date of the incurrence of Incremental Term Loans, the Borrower hereby represents and
warrants for the benefit of the Lenders (including the Incremental Lenders) and the
Administrative Agent that all of the conditions to effectiveness set forth in preceding
Section 5 have been satisfied. The Borrower acknowledges and agrees that the foregoing shall
be deemed a representation and warranty made pursuant to the Credit Agreement for all
purposes.
	 
	7.	 	Pursuant to Section 1.14(c) of the Credit Agreement, each of the Incremental Term Loans made
hereunder shall be added to (and form part of) each Borrowing of outstanding Initial Term
Loans on a pro rata basis (based on relative sizes of the various outstanding
Borrowings) so that each Lender with Initial Term Loans shall participate proportionately in
each then outstanding Borrowing of Initial Term Loans. The Borrower hereby covenants and
agrees to compensate each Incremental Lender making Incremental Term Loans hereunder for
funding Eurodollar Loans during an existing Interest Period as such request for compensation
may be made by such Incremental Lender.
	 
	8.	 	As an additional term applicable to the Incremental Term Loans made hereunder, the Borrower
hereby covenants and agrees, for the benefit of the Incremental Lenders pursuant to this
Agreement (and their successors and assigns), that from and after the Agreement Effective Date
and until the Incremental Commitments have terminated and the Incremental Term Loans made
pursuant to this Agreement (together with interest thereon), Fees and all other Obligations
(other than any indemnities described in Section 13.13 which are not then due and payable)
relating thereto (whether incurred under this Agreement or the other Credit Documents), are
paid in full, the Borrower will not permit the Secured Leverage Ratio at any time during a
period set forth below to be greater than the ratio set forth opposite such period below:

	 	 	 
	Period	 	Ratio
	March 31, 2008 to and including the
day immediately before the last day
of the Borrower’s fiscal quarter
ended closest to June 30, 2008

	 	5.25:1
	 
	 	 
	Last day of the Borrower’s fiscal
quarter ended closest to June 30,
2008 to and including the day
immediately before the last day of
the Borrower’s fiscal quarter ended
closest to December 31, 2008

	 	5.00:1
	 
	 	 
	Last day of the Borrower’s fiscal
quarter ended closest to December 31,
2008 to and including the day
immediately before the last day of
the Borrower’s fiscal quarter ended
closest to December 31, 2009

	 	4.50:1
	 
	 	 

 

 

Annex I

Page 6

	 	 	 
	Period	 	Ratio
	Last day of the Borrower’s fiscal
quarter ended closest to December 31, 2009 to and including the day
immediately before the last day of
the Borrower’s fiscal quarter ended
closest to December 31, 2010

	 	4.00:1
	 
	 
	 	 
	Last day of the Borrower’s fiscal
quarter ended closest to December 31,
2010 to and including the day
immediately before the last day of
the Borrower’s fiscal quarter ended
closest to December 31, 2011

	 	3.50:1
	 
	 	 
	Last day of the Borrower’s fiscal
quarter ended closest to December 31,
2011 to and including the day
immediately before the last day of
the Borrower’s fiscal quarter ended
closest to December 31, 2012

	 	3.25:1
	 
	 	 
	Last day of the Borrower’s fiscal
quarter ended closest to December 31,
2012 and thereafter

	 	3.00:1

	9.	 	Each Incremental Lender party hereto, and each of its successors and assigns, in each case as
to itself only, hereby agrees that if it assigns any Initial Term Loans at a time when the
covenant contained in Section 8 is in effect, it shall specify in the respective assignment
whether (and to what extent) the Initial Term Loans being assigned also constitute Incremental
Term Loans made pursuant to this Agreement.
	 
	10.	 	As an additional term applicable to the Incremental Term Loans made hereunder, the Borrower
hereby covenants and agrees that, promptly after the effectiveness hereof, it shall offer an
amendment to the Credit Agreement to the Lenders thereunder (the “Proposed
Amendment”), which Proposed Amendment shall be in form reasonably satisfactory to the
Administrative Agent and be prepared by its counsel, (it being acknowledged and agreed by the
parties hereto that the draft dated November 13, 2007 of the First Amendment to the Credit
Agreement (the “Draft Amendment”) is in acceptable form) and which Proposed Amendment
shall (x) offer to the Lenders an amendment to the Credit Agreement which shall incorporate a
Secured Leveraged Ratio covenant for the benefit of all Lenders with the same maximum ratios
as are set forth above in preceding
Section 8 (with the portion of the Proposed Amendment adding the covenant described in this
clause (x) being herein called the “Additional Covenant Amendment”), which Additional
Covenant Amendment shall become effective upon the execution of the Proposed Amendment by the
parties specified in the Draft Amendment, including the Required Lenders, and (y) offer to
the Lenders holding outstanding Revolving Obligations (or Revolving Loan Commitments in
respect thereof) a modification to Section 9.07 of the Credit Agreement which would modify
same to provide the same maximum ratios as are proposed pursuant to the Additional Covenant
Amendment, it

 

 

Annex I

Page 7

	 	 	being acknowledged and agreed that the Amendment described in this clause (y)
would become effective upon the execution of the Proposed Amendment by the parties
contemplated in the Draft Amendment, including the Majority Lenders holding outstanding
Revolving Obligations (or Revolving Loan Commitments in respect thereof). The Borrower
further agrees to cooperate with the Administrative Agent in seeking to obtain the approval
of the amendment described in the immediately preceding sentence (although the Borrower shall
not be obligated to pay fees to the Lenders to obtain their approval of said Amendment). If
the Additional Covenant Amendment (regardless of whether the portion of the Proposed
Amendment described in clause (y) of the preceding sentence) becomes effective on or prior to
January 31, 2008, the parties hereto agree that the provisions of preceding Section 8 and
following Section 11 shall, from and after the date of the effectiveness of the Additional
Covenant Amendment, cease to have further force or effect. The Borrower further agrees to
cause all of its Subsidiaries which are Credit Parties, promptly upon request of the
Administrative Agent, to execute and deliver copies of the Proposed Amendment and to
cooperate with the Administrative Agent in seeking the approval and execution thereof
(although the Borrower shall not be obligated to pay fees to the Lenders to obtain their
approval of said Amendment).

	11.	 	The Borrower hereby agrees, as an additional term applicable to Incremental Term Loans made
hereunder, that if at any time there is breach or default of the covenant set forth above in
Section 8 or in Section 10, then the holders of a majority of the outstanding principal amount
of the Incremental Term Loans made pursuant to this Agreement may, or may direct the
Administrative Agent to, accelerate the maturity of all then outstanding Incremental Term
Loans made pursuant to this Agreement. The Borrower further agrees, for the benefit of the
Lenders party to the Credit Agreement, that any acceleration of obligations to the immediately
preceding sentence shall result in an immediate Event of Default pursuant to the Credit
Agreement.
	 
	12.	 	The Borrower hereby covenants and agrees to, and to cause each of the Credit Parties to, take
all actions specified in Section 5(ix) immediately following the Acquisition on the Agreement
Effective Date.
	 
	13.	 	The Borrower and the other Credit Parties, by executing and delivering the Agreement to which
this Annex I is attached, hereby agree that, upon the execution and delivery of said
Agreement, same shall constitute a “Credit Document” for all purposes of the Credit Agreement
and the other Credit Documents.
	 
	14.	 	The Incremental Commitment of each Incremental Lender under this Agreement shall terminate on
November 20, 2007 unless the Acquisition has been consummated on or prior to such date. The
Borrower shall have the right, at any time upon written notice to the Administrative Agent, to
terminate the commitments of the Incremental Lenders under this Agreement.exv4w1

 

Exhibit
4.1

REGISTRATION RIGHTS AGREEMENT

     THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of November 15, 2007, by and
among Hansen Medical, Inc., a Delaware corporation (the “Company”), and the investors listed on
Schedule A hereto, each of which is herein referred to as an “Investor”.

RECITALS

     WHEREAS, the Company, Redwood Merger Subsidiary, Inc., a Delaware corporation and a
wholly-owned subsidiary of the Company (“Merger Sub”), Second Redwood Merger Subsidiary, Inc., a
Delaware corporation and a wholly-owned, first tier subsidiary of the Company, Aortx, Inc., a
Delaware corporation and David Forster and Louis Cannon, as Stockholders’ Representatives, have
entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”); and

     WHEREAS, pursuant to the Merger Agreement, each of the Investors will be issued shares of the
Company’s Common Stock as consideration thereunder upon and following the Effective Time (as
defined therein), and it is a condition to such Investors acceptance of such shares of Common Stock
as a form of consideration thereunder that the Company enter into this Agreement with the Investors
with respect to the Company’s registration of such shares of Common Stock for resale under the Act
(as defined below) upon and subject to the terms and conditions set forth herein.

     NOW, THEREFORE, FOR GOOD AND VALUABLE CONSIDERATION, THE PARTIES HEREBY AGREE AS FOLLOWS:

     1. Registration Rights. The Company covenants and agrees as follows:

          1.1 Definitions. For purposes of this Section 1:

               (a) The term “Act” means the Securities Act of 1933, as amended.

               (b) The term “Common Stock” means the Company’s Common Stock.

               (c) The term “Form S-3” means such form under the Act as in effect on the date hereof or any
registration form under the Act subsequently adopted by the SEC that permits inclusion or
incorporation of substantial information by reference to other documents filed by the Company with
the SEC, or, if the Company is not then qualified to use Form S-3, Form S-1 or such successor or
other appropriate form.

               (d) The term “Holder” means any person owning or having the right to acquire Registrable
Securities or any assignee thereof in accordance with Section 1.9 hereof.

 

 

               (e) The term “1934 Act” means the Securities Exchange Act of 1934, as amended.

               (f) The terms “register,” “registered,” and “registration” refer to a registration effected by
preparing and filing a registration statement or similar document in compliance with the Act, and
the declaration or ordering of effectiveness of such registration statement or document.

               (g) The term “Registrable Securities” means any shares of the Company’s Common Stock issued
pursuant to the Merger Agreement and any shares of the Company’s Common Stock issued to any Holder
with respect to any Registrable Securities by way of stock dividend or stock split, or in
connection with a combination, recapitalization, reorganization, merger or consolidation of the
Company.

               (h) The term “Rule 144” shall mean Rule 144 under the Act.

               (i) The term “Rule 144(k)” shall mean subsection (k) of Rule 144 under the Act.

               (j) The term “SEC” shall mean the Securities and Exchange Commission.

               (k) Any defined terms not otherwise defined herein shall have the meanings assigned to them in
the Merger Agreement.

          1.2 Form S-3 Registration.

               (a) Initial Consideration. The Company shall use its commercially reasonable efforts
to prepare and file with the SEC a registration statement on Form S-3 (a “Registration Statement”)
under the Securities Act with respect to the Registrable Securities issued to the Investors as
Initial Consideration pursuant to the Merger Agreement, and to cause such Registration Statement to
be declared effective by the SEC no later than January 31, 2008. The Company shall deliver to each
holder of Registrable Securities so issued, including any permitted transferees reflected in the
stockholder records of the Company (each, a “Holder”), in writing at the address set forth in the
stockholder records of the Company, notice that such Registration Statement has been declared
effective by the SEC within two (2) Business Days following such declaration by the SEC.

               (b) Milestone Consideration. On or before the date that is forty five (45) days after
each date upon which the Company issues Registrable Securities to the Investors as Milestone
Consideration, the Company shall use its commercially reasonable efforts to prepare and file with
the SEC a Registration Statement under the Securities Act with respect to the Registrable
Securities issued to the Investors as Milestone Consideration pursuant to the Merger Agreement, and
to cause such Registration Statement to be declared effective by the SEC within such forty five
(45) day period. The Company shall deliver to each Holder, in writing at the address set forth in
the stockholder records of the Company, notice that such Registration Statement has been declared
effective by the SEC within two (2) Business Days following such declaration by the SEC.

2

 

          1.3 Obligations of the Company. Whenever required under this Section 1 to effect the
registration of any Registrable Securities, the Company shall, as expeditiously as reasonably
possible:

               (a) Keep such Registration Statement effective until the earlier of (i) two (2) years
following the date of the effectiveness of such Registration Statement, and (ii) the date that all
remaining outstanding Registrable Securities can be sold pursuant to Rule 144 under the Securities
Act (the “Registration Effective Period”);

               (b) prepare and file with the SEC such amendments and supplements to such Registration
Statement and the prospectus used in connection with such Registration Statement as may be
necessary to comply with the provisions of the Act with respect to the disposition of all
securities covered by such Registration Statement;

               (c) furnish to the Holders such number of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable Securities owned by them;

               (d) use all commercially reasonable efforts to register and qualify the securities covered by
such Registration Statement under such other securities or Blue Sky laws of such jurisdictions as
shall be reasonably requested by the Holders, provided that the Company shall not be required in
connection therewith or as a condition thereto to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions;

               (e) notify each Holder of Registrable Securities covered by such Registration Statement at any
time when a prospectus relating thereto is required to be delivered under the Act of the happening
of any event as a result of which the prospectus included in such Registration Statement, as then
in effect, includes an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances then existing;

               (f) cause all such Registrable Securities registered pursuant to this Section 1 to be listed
on each securities exchange and trading system on which similar securities issued by the Company
are then listed; and

               (g) provide a transfer agent and registrar for all Registrable Securities registered pursuant
to this Agreement and a CUSIP number for all such Registrable Securities, in each case not later
than the effective date of such registration.

     Notwithstanding the provisions of this Section 1, the Company shall be entitled to postpone or
suspend, for a reasonable period of time, the trading under, any Registration Statement whenever,
and only for so long as, in the reasonable judgment of the Company after consultation with counsel
there is in existence material undisclosed information or events with respect to the Company (the
“Suspension Right”). The Company will notify each Holder in writing at least two (2) business days
in advance of the Company’s initiation of such Suspension Right. In the event the Company
exercises the Suspension Right, such suspension will continue only for the period of time
reasonably necessary for disclosure to occur at a time that is not

3

 

materially detrimental to the Company and its stockholders or until such time as the
information or event is no longer material, each as determined in good faith by the Company (the
“Suspension Period”). The Company will notify each Holder in writing within two (2) business days
following the Company’s termination of any Suspension Period. The Registration Effective Period
shall be extended by the total number of days as to which the Suspension Right is in effect. The
Suspension Right shall not be invoked during any period when officers or directors of the Company
are permitted to trade in the Company’s stock.

          1.4 Information from Holder. In connection with the registration of the
Registrable Securities pursuant to each Registration Statement pursuant to Section 1 hereof, each
Holder shall provide the Company with such information as may be required by Section 507 of
Regulation S-K of the Securities Act, together with whatever confirmations, information requests,
certificates or consents as may reasonably be requested by the Company.

          1.5 Expenses of Registration. All expenses, including (without limitation) all
registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements
of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling
Holders (not to exceed $25,000 with respect to any one (1) Registration Statement) shall be borne
by the Company.

          1.6 Indemnification. In the event any Registrable Securities are included in a
Registration Statement under this Section 1:

               (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder,
the partners, officers, directors and stockholders of each Holder, legal counsel and accountants
for each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any,
who controls such Holder or underwriter within the meaning of the Act or the 1934 Act, against any
losses, claims, damages or liabilities (joint or several) to which they may become subject under
the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the
Act, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise
out of or are based upon any of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in
such Registration Statement, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state in
such Registration Statement a material fact required to be stated therein, or necessary to make the
statements therein not misleading or (iii) any violation or alleged violation by the Company of the
Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act,
the 1934 Act or any state securities laws, and the Company will reimburse each such Holder,
underwriter, controlling person or other aforementioned person for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such loss, claim,
damage, liability or action as such expenses are incurred; provided, however, that the indemnity
agreement contained in this subsection l.6(a) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability or action if such settlement is effected without the consent of
the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in
any such case for any such loss, claim, damage, liability or action to the extent that it arises
out of or is based upon a Violation that occurs in reliance upon and in conformity with

4

 

written information furnished expressly for use in connection with such registration by any
such Holder, underwriter, controlling person or other aforementioned person; provided further,
however, that the foregoing indemnity agreement with respect to any preliminary prospectus shall
not inure to the benefit of any Holder or underwriter or other aforementioned person, or any person
controlling such Holder or underwriter, from whom the person asserting any such losses, claims,
damages or liabilities purchased shares in the offering, if a copy of the most current prospectus
was not sent or given by or on behalf of such Holder or underwriter or other aforementioned person
to such person, if required by law to have been so delivered, at or prior to the written
confirmation of the sale of the shares to such person, and if the prospectus (as so amended or
supplemented) would have cured the defect giving rise to such loss, claim, damage or liability.

               (b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the
Company, each of its directors, each of its officers who has signed the Registration Statement,
each person, if any, who controls the Company within the meaning of the Act, legal counsel and
accountants for the Company, any underwriter, any other Holder selling securities in such
Registration Statement and any controlling person of any such underwriter or other Holder, against
any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons
may become subject, under the Act, the 1934 Act, any state securities laws or any rule or
regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar as such
losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based
upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs
in reliance upon and in conformity with written information furnished by such Holder expressly for
use in connection with such registration; and each such Holder will reimburse any person intended
to be indemnified pursuant to this subsection l.6(b) for any legal or other expenses reasonably
incurred by such person in connection with investigating or defending any such loss, claim, damage,
liability or action as such expenses are incurred; provided, however, that the indemnity agreement
contained in this subsection l.6(b) shall not apply to amounts paid in settlement of any such loss,
claim, damage, liability or action if such settlement is effected without the consent of the Holder
(which consent shall not be unreasonably withheld), and provided that in no event shall any
indemnity under this subsection l.6(b) exceed the net proceeds from the offering received by such
Holder except in the case of fraud or willful misrepresentation by such Holder.

               (c) Promptly after receipt by an indemnified party under this Section 1.6 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 1.6,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying
party shall have the right to participate in and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an indemnified party
(together with all other indemnified parties that may be represented without conflict by one
counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid
by the indemnifying party, if representation of such indemnified party by the counsel retained by
the indemnifying party would be inappropriate due to actual or potential differing interests
between such indemnified party and any other party represented by such counsel in such proceeding.
The failure to deliver written notice to the

5

 

indemnifying party within a reasonable time of the commencement of any such action, if
prejudicial to its ability to defend such action, shall relieve such indemnifying party of any
liability to the indemnified party under this Section 1.6, but the omission to so deliver written
notice to the indemnifying party will not relieve it of any liability that it may have to any
indemnified party otherwise than under this Section 1.6.

               (d) If the indemnification provided for in this Section 1.6 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim,
damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such
indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such loss, liability, claim, damage or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and the
indemnified party on the other hand in connection with the statements or omissions that resulted in
such loss, liability, claim, damage or expense, as well as any other relevant equitable
considerations; provided, however, that no contribution by any Holder, when combined with any
amounts paid by such Holder pursuant to Section 1.6(b), shall exceed the net proceeds from the
offering received by such Holder except in the case of fraud or willful misrepresentation by such
Holder. The relative fault of the indemnifying party and the indemnified party shall be determined
by reference to, among other things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to information supplied
by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission.

               (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the
underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control.

               (f) The obligations of the Company and Holders under this Section 1.6 shall survive the
completion of any offering of Registrable Securities in a Registration Statement under this
Section 1 and otherwise.

          1.7 Reports Under the 1934 Act. With a view to making available to the Holders the
benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a
Holder to sell securities of the Company to the public without registration or pursuant to a
registration on Form S-3, the Company agrees to:

               (a) make and keep public information available, as those terms are understood and defined in
Rule 144, at all times after the date of this Agreement;

               (b) file with the SEC in a timely manner all reports and other documents required of the
Company under the Act and the 1934 Act; and

               (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i) a written statement by the Company that it has complied with the reporting
requirements of Rule 144 (at any time after ninety (90) days after the

6

 

effective date of the first registration statement filed by the Company), the Act and the 1934
Act (at any time after it has become subject to such reporting requirements), or that it qualifies
as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so
qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other
reports and documents so filed by the Company, and (iii) such other information as may be
reasonably requested to avail any Holder of any rule or regulation of the SEC that permits the
selling of any such securities without registration or pursuant to such form.

          1.8 Assignment of Registration Rights. The rights granted to the Investors under this
Agreement shall not be assigned to any other party.

     2. Miscellaneous.

          2.1 Successors and Assigns. Except as otherwise provided herein, the terms and
conditions of this Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties (including transferees of any shares of Registrable
Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party
other than the parties hereto or their respective successors and assigns any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement.

          2.2 Governing Law. This Agreement shall be governed by and construed under the laws
of the State of California as applied to agreements among California residents entered into and to
be performed entirely within California.

          2.3 Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.

          2.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

          2.5 Notices. All notices and other communications given or made pursuant hereto shall
be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be
notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business
hours of the recipient; if not, then on the next business day, (iii) five (5) days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt. All communications shall be sent to the respective parties
at the addresses set forth on the signature pages attached hereto (or at such other addresses as
shall be specified by notice given in accordance with this Section 2.5).

          2.6 Expenses. If any action at law or in equity is necessary to enforce or interpret
the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees,
costs and necessary disbursements in addition to any other relief to which such party may be
entitled.

7

 

          2.7 Entire Agreement; Amendments and Waivers. This Agreement (including the Exhibits
hereto, if any) constitutes the full and entire understanding and agreement among the parties with
regard to the subjects hereof and thereof. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively) only with the written consent of the Company
and the holders of a majority of the Registrable Securities. Any amendment or waiver effected in
accordance with this paragraph shall be binding upon each holder of any Registrable Securities,
each future holder of all such Registrable Securities, and the Company.

          2.8 Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision(s) shall be excluded from this Agreement and the
balance of the Agreement shall be interpreted as if such provision(s) were so excluded and shall be
enforceable in accordance with its terms.

          2.9 Aggregation of Stock. All shares of Registrable Securities held or acquired by
affiliated entities (including affiliated venture capital funds) or persons shall be aggregated
together for the purpose of determining the availability of any rights under this Agreement.

(Remainder of Page Intentionally Left Blank)

8

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of
the date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	/s/ Fred Moll 

	 
	 	 	 	 
	 

	 	By:
	 	Fred Moll
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	CEO
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	  

	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Thomas Afzal
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Thomas Afzal
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Greg W. Stone
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Greg W. Stone
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Kemal Schankareli
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Kemal Schankareli
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ France Dixon Helfer
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	France Dixon Helfer
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ John Lonergan
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	John Lonergan
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Ji Zhang
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Ji Zhang
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Christopher Gross
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Christopher Gross
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	INVESTOR:	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jeff Christian
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Jeff Christian
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ William O’Neill
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	William O’Neill
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ George Caffell
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	George Caffell
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ William F. Fearon
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	William F. Fearon
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	JAIC-Henson MedFocus Accelerator Fund, LLC
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jeff Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Jeff Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	Manager
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	JAIC-Henson MedFocus Fund II, LLC
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jeff Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Jeff Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	Manager
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	HBM-MedFocus, LLC
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jeff Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Jeff Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	Manager
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jeffrey J. Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Jeffrey J. Valko
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Daniel Murray
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Daniel Murray
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Yen Liao
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Yen Liao
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ David C. Forster
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	David C. Forster
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Robert J. Chin
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Robert J. Chin
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	Bio-Star Private Equity Fund FP, LLC
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Louis A. Cannon, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Louis A. Cannon, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	Bio-Star Private Equity Fund, LLC
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Louis A. Cannon, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Louis A. Cannon, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Kenton J. Zehr
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Kenton J. Zehr
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Geoff Dillon
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Geoff Dillon
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Alex T. Roth
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Alex T. Roth
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Mark Reisman
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Mark Reisman
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ James J. Leftwich
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	James J. Leftwich
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	Fitz Partners, L.P.
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Peter Fitzgerald
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Peter Fitzgerald
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 

	 

	 	Name:	 	 
	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Peter Fitzgerald
	 

	 	 	 	 
	 

	 	Name:
	 	Peter Fitzgerald 

	 

	 	Title:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 

	 

	 	By:	 	 
	 

	 	 	 	 

	 

	 	Name:	 	 
	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	Address:
	 	 	 	 
	 	 	 

	 	 	 

	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	WS Investment Company, LLC (2004A)
	 
	 	 	 	 
	 

	 	By:
	 	/s/ J. Casey McGlynn 

	 

	 	Name:
	 	J. Casey McGlynn 

	 

	 	Title:
	 	Member 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 

	 

	 	By:	 	 
	 

	 	 	 	 

	 

	 	Name:	 	 
	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	WS Investment Company, LLC (2004D)
	 
	 	 	 	 
	 

	 	By:
	 	/s/ J. Casey McGlynn 

	 

	 	Name:
	 	J. Casey McGlynn 

	 

	 	Title:
	 	Member 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 

	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 

	 

	 	Name:	 	 
	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	Address:
	 	 	 	 
	 	 	 

	 	 	 

	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Steven Bailey 

	 

	 	Name:
	 	Steven Bailey 

	 

	 	Title:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

 

 

     IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 

	 

	 	By:	 	 
	 

	 	 	 	 

	 

	 	Name:	 	 
	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Louis A. Cannon, M.D. 

	 

	 	Name:
	 	Louis A. Cannon, M.D. 

	 

	 	Title:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 

	 

	 	Name:	 	 
	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	Address:
	 	 	 	 
	 	 	 

	 	 	 

	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	Robert M. Curtis and Patricia M. Marcus, Trustees
of the Curtis/Marcus Family Trust Dated April 11,
2002
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Robert M. Marcus 

	 

	 	By:
	 	/s/ Patricia M. Marcus 

	 

	 	Name:
	 	Robert M. Marcus, Patricia M. Marcus 

	 

	 	Title:
	 	Trustees 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 

	 

	 	By:	 	 
	 

	 	Name:
	 	 

	 

	 	 	 	 

	 

	 	Title:	 	 
	 

	 	 	 	 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	Flea Street Translational, LLC
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Ted Tussing 

	 

	 	Name:
	 	Ted Tussing 

	 

	 	Title:
	 	Member 

	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 

	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Marc Sakwa, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Marc Sakwa, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Richard Ginn
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Richard Ginn
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Thomas K. Jones, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Thomas Jones, M.D.
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Liisa Ann Larson
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Liisa Ann Larson
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Renee Masi
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Renee Masi
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Matthew Pease
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Matthew Pease
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	Saratoga Ventures IV, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Foster D. Hendrix
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Foster D. Hendrix
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	General Partner
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	Saratoga Ventures V, L.P.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Foster D. Hendrix
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Foster D. Hendrix
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	General Partner
	 

	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 	 	St. Jude Medical, Inc.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ John C. Heinmiller
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	John C. Heinmiller
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:
	 	Executive Vice President and CFO
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Brandon Walsh
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Brandon Walsh
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Scott Heneveld
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Scott Heneveld
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

          IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written.

	 	 	 	 	 
	 	 	HANSEN MEDICAL, INC.
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Thuzar Han
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Name:
	 	Thuzar Han
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Address:
	 	 	 	 
	 	 	 
	 
	 	 	 	 
	 	 	 

 

 

     SCHEDULE A

1. Bio-Star Private Equity Fund FP, LLC

2. Bio-Star Private Equity Fund, LLC

3. George Caffell

4. Robert Chin, Ph.D.

5. Jeff Christian

6. Robert M. Curtis and Patricia M. Marcus, Trustees of the Curtis/Marcus Family Trust Dated April 11, 2002

7. Geoff Dillon

8. Fitz Partners, LP

9. Flea Street Translational, LLC

10. David C. Forster, P.E.

11. Richard Ginn

12. Chris Gross

13. HBM-MedFocus, LLC

14. Scott Heneveld

15. JAIC-Henson MedFocus Fund II, LLC

16. Liisa Ann Larson

17. James J. Leftwich

18. Yen Liao

19. John Lonergan

20. Daniel Murray

21. Matthew Pease

22. Alex T. Roth

23. Ted Tussing

24. Jeffrey Valko

25. JAIC-Henson MedFocus Accelerator Fund, LLC

26. Saratoga Ventures IV, LP

27. Saratoga Ventures V, L.P.

28. St. Jude Medical, Inc.

29. WS Investment Company, LLC (2004A)

30. WS Investment Company, LLC (2004D)

31. Steven Bailey

32. Brian Beckey

33. Louis Cannon

34. William F. Fearon, M.D.

35. Peter J. Fitzgerald, M.D.

36. Thuzar Han

37. Thomas Jones

38. Renee Masi

39. William O’Neill

40. Mark Reisman

41. Marc Sakwa, M.D.

42. Brandon Walsh

43. Kenton Zehr

44. Ji Zhang

45. France Dixon Helfer

46. Kem Schankareli

47. Thomas Afzal

48. Greg Stone

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]